scholarly journals Safety Assessment of Vitamin D and Its Photo-Isomers in UV-Irradiated Baker’s Yeast

Foods ◽  
2021 ◽  
Vol 10 (12) ◽  
pp. 3142
Author(s):  
Tobias Schümmer ◽  
Gabriele I. Stangl ◽  
Wim Wätjen
Keyword(s):  
Vitamin D ◽  
Uv Irradiation ◽  
Health Concern ◽  
Vegan Diet ◽  
Current Status ◽  
Vitamin D2 ◽  
Food Ingredient ◽  
Potential Health ◽  
Novel Food ◽  
Baked Goods

Vitamin D deficiency due to, e.g., nutritional and life style reasons is a health concern that is gaining increasing attention over the last two decades. Vitamin D3, the most common isoform of vitamin D, is only available in food derived from animal sources. However, mushrooms and yeast are rich in ergosterol. This compound can be converted into vitamin D2 by UV-light, and therefore act as a precursor for vitamin D. Vitamin D2 from UV-irradiated mushrooms has become an alternative source of vitamin D, especially for persons pursuing a vegan diet. UV-irradiated baker´s yeast (Saccharomyces cerevisiae) for the production of fortified yeast-leavened bread and baked goods was approved as a Novel Food Ingredient in the European Union, according to Regulation (EC) No. 258/97. The Scientific Opinion provided by the European Food Safety Authority Panel on Dietetic Products, Nutrition, and Allergies has assessed this Novel Food Ingredient as safe under the intended nutritional use. However, recent findings on the formation of side products during UV-irradiation, e.g., the photoproducts tachysterol and lumisterol which are compounds with no adequate risk assessment performed, have only been marginally considered for this EFSA opinion. Furthermore, proceedings in analytics can provide additional insights, which might open up new perspectives, also regarding the bioavailability and potential health benefits of vitamin D-fortified mushrooms and yeast. Therefore, this review is intended to give an overview on the current status of UV irradiation in mushrooms and yeast in general and provide a detailed assessment on the potential health effects of UV-irradiated baker´s yeast.

scholarly journals Vitamin D2 and D3 Supplementation Effect on Serum 25(OH)D Levels: A Meta-Analysis

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 1782-1782
Author(s):  
Meline Chakalian ◽  
Joyce Cao ◽  
Jiang Hu ◽  
Casey Vanous ◽  
Simon Sum
Keyword(s):  
Vitamin D ◽  
Meta Analysis ◽  
Small Sample ◽  
Relative Potency ◽  
Health Concern ◽  
Outcome Variable ◽  
Vitamin D2 ◽  
Baseline Serum ◽  
Meta Regression ◽  
The Impact

Abstract Objectives Vitamin D insufficiency is a global health concern that affects nearly 50% of the population worldwide. Growing demand for vegan/vegetarian products has aroused interest in the plant-sourced D2 form for use in dietary supplements. However, vitamin D2’s ability to raise serum 25(OH)D levels in relation to D3 among existing scientific literature is inconclusive. This study sought to compare vitamin D2 to D3 in increasing serum 25(OH)D levels in order to better understand the relative potency and dosage required to address vitamin D insufficiencies. Methods PubMed and Embase databases were searched through July of 2018. Randomized controlled trials comparing D2 and D3 supplementation of equivalent dosages and the resulting increase in serum 25(OH)D levels in adults were eligible for this meta-analysis. A meta regression was conducted to compare the impact of both vitamin D forms on serum 25(OH)D levels. The outcome variable evaluated was the serum 25(OH)D levels. Results Nine RCTs (n = 628) with vitamin D dose ranging from 10 mcg per day to 1250 mcg per week, and an intervention duration from 2 to 16 weeks were eligible. Subjects included healthy adults as well as those with chronic kidney disease. There was substantial heterogeneity among the studies (I2 = 78.07%). The meta-regression showed vitamin D supplementation regardless of form was effective in raising serum 25(OH)D levels (P < 0.0001). The mean effect size expressed as the standardized mean difference (SMD) from baseline serum 25(OH)D levels was 1.16 [95% CI: 0.83, 1.49] for D2 and 1.52 [95% CI: 0.99, 2.04] for D3. While there was a trend of greater increase caused by D3 numerically, the difference between D2 and D3 was not statistically significant. When duration and frequency of supplementation were examined, similar trends of non-significant greater increases for D3 relative to D2 were observed. Conclusions This research shows both vitamin D2 and D3 supplementation can significantly increase serum 25(OH)D levels. Though the results did not reach statistical significance, there is a consistent trend of vitamin D3 offering additional effectiveness relative to D2. The high heterogeneity across studies and small sample size likely contributed to the non-significant results and limited the ability to identify a quantitative relative potency that can be used for a D2 dosage recommendation. Funding Sources None.

scholarly journals Acorn Oil: Chemistry and Functionality

2020 ◽  
Vol 2020 ◽  
pp. 1-11
Author(s):  
Mehdi Taib ◽  
Lahboub Bouyazza ◽  
Badiaa Lyoussi
Keyword(s):  
Type 2 Diabetes ◽  
Essential Fatty Acids ◽  
Health Benefits ◽  
Extraction Methods ◽  
Food Ingredient ◽  
Potential Health ◽  
Novel Food ◽  
Excellent Source ◽  
Palmitic Acids

Acorn oil has been receiving increasing attention due to its nutritional potentials. However, its application as a novel food ingredient has not yet been fully explored. This paper summarizes chemical composition, extraction methods, potential health benefits, and current applications of acorn oil, with the aim of providing suggestions for its exploitation. Acorn oil is an excellent source of essential fatty acids (oleic, linoleic, α-linolenic, and palmitic acids). Acorns are a rich source of tocopherols, with γ-tocopherol being the most abundant. It also contains various bioactive compounds such as polyphenols and sterols (mainly β-sitosterol). Diets enriched with acorn oil can be beneficial in preventing cardiovascular disease (CVD), cancer, and type 2 diabetes as well as offer antioxidant activity. Further studies should focus on producing better quality acorn oil such as the application of more innovative and optimized techniques that can increase its health benefits and hence utilization.

scholarly journals Pooled estimate of vitamin D deficiency among pregnant women in India: a systematic review and meta-analysis

2021 ◽  
Vol 40 (1) ◽  
Author(s):  
Angeline Jeyakumar ◽  
Vidhya Shinde ◽  
Reshma Ravindran
Keyword(s):  
Systematic Review ◽  
Vitamin D ◽  
Pregnant Women ◽  
Vitamin D Deficiency ◽  
Meta Analysis ◽  
Health Concern ◽  
Study Quality ◽  
Care Services ◽  
Pooled Prevalence ◽  
Women In India

Abstract Background Vitamin D deficiency among pregnant women is a public health concern globally. In India, individual studies report high prevalence. However, lack of national data masks the true burden. This work determined the pooled prevalence of vitamin D deficiency among pregnant women in India through a systematic review of literature and meta-analysis. Methods Three different search engines yielded 15 eligible articles. Study quality was assessed by 10 different criteria and summary of study quality was categorized as per Cochrane standards. Meta-analysis was performed to estimate pooled prevalence of vitamin D deficiency among healthy pregnant women and heterogeneity among selected studies. A sample of n = 4088 was used to study the pooled prevalence among pregnant women. Results The random effects combined estimate was 32.35% (95% CI, (12.58–117.48). High heterogeneity (tau2 = 0.39, I2 = 100%) and high risk of bias was observed among the selected studies. The test for overall effect was observed to be z = 2.54(P = 0.01). Conclusion Pooled estimate > 30% emphasizes the need for screening through antenatal care services and initiate preventive measures to address the deficiency.

scholarly journals In Vitro Bioaccessibility of Bioactive Compounds from Citrus Pomaces and Orange Pomace Biscuits

Molecules ◽  
2021 ◽  
Vol 26 (12) ◽  
pp. 3480
Author(s):  
Adriana Maite Fernández-Fernández ◽  
Eduardo Dellacassa ◽  
Tiziana Nardin ◽  
Roberto Larcher ◽  
Adriana Gámbaro ◽  
...  
Keyword(s):  
Bioactive Compounds ◽  
Total Phenol Content ◽  
No Production ◽  
Food Ingredient ◽  
Potential Health ◽  
Raw264.7 Macrophages ◽  
In Vitro Bioaccessibility ◽  
Health Promoting ◽  
Orange Pomace

The present investigation aimed to provide novel information on the chemical composition and in vitro bioaccessibility of bioactive compounds from raw citrus pomaces (mandarin varieties Clemenule and Ortanique and orange varieties Navel and Valencia). The effects of the baking process on their bioaccessibility was also assessed. Samples of pomaces and biscuits containing them as an ingredient were digested, mimicking the human enzymatic oral gastrointestinal digestion process, and the composition of the digests were analyzed. UHPLC-MS/MS results of the citrus pomaces flavonoid composition showed nobiletin, hesperidin/neohesperidin, tangeretin, heptamethoxyflavone, tetramethylscutellarein, and naringin/narirutin. The analysis of the digests indicated the bioaccessibility of compounds possessing antioxidant [6.6–11.0 mg GAE/g digest, 65.5–97.1 µmol Trolox Equivalents (TE)/g digest, and 135.5–214.8 µmol TE/g digest for total phenol content (TPC), ABTS, and ORAC-FL methods, respectively; significant reduction (p < 0.05) in Reactive Oxygen Species (ROS) formation under tert-butyl hydroperoxide (1 mM)-induced conditions in IEC-6 and CCD-18Co cells when pre-treated with concentrations 5–25 µg/mL of the digests], anti-inflammatory [significant reduction (p < 0.05) in nitric oxide (NO) production in lipopolysaccharide (LPS)-induced RAW264.7 macrophages], and antidiabetic (IC50 3.97–11.42 mg/mL and 58.04–105.68 mg/mL for α-glucosidase and α-amylase inhibition capacities) properties in the citrus pomaces under study. In addition, orange pomace biscuits with the nutrition claims “no-added sugars” and “source of fiber”, as well as those with good sensory quality (6.9–6.7, scale 1–9) and potential health promoting properties, were obtained. In conclusion, the results supported the feasibility of citrus pomace as a natural sustainable source of health-promoting compounds such as flavonoids. Unfractionated orange pomace may be employed as a functional food ingredient for reducing the risk of pathophysiological processes linked to oxidative stress, inflammation, and carbohydrate metabolism, such as diabetes, among others.

scholarly journals Testing the Toxicity of Stachybotrys chartarum in Indoor Environments—A Case Study

Energies ◽  
2021 ◽  
Vol 14 (6) ◽  
pp. 1602
Author(s):  
Marlena Piontek ◽  
Katarzyna Łuszczyńska
Keyword(s):  
Health Concern ◽  
Major Constituent ◽  
Stachybotrys Chartarum ◽  
Malt Extract ◽  
Indoor Environments ◽  
Class Iii ◽  
Potential Health ◽  
Dugesia Tigrina ◽  
Ecotoxicological Tests ◽  
Interior Walls

Infestation of interior walls of buildings with fungal mould is a reason for health concern which is exacerbated in energy-efficient buildings that limit air circulation. Both mycological and mycotoxicological studies are needed to determine the potential health hazards to residents. In this paper, a rare case of the occurrence of Stachybotrys chartarum in an apartment building in the Lubuskie Province in Poland has been described. Isolated as the major constituent of a mixed mycobiota, its specific health relevance still needs to be carefully analyzed as its biochemical aptitude for the synthesis of mycotoxins may be expressed at different levels. Therefore, ecotoxicological tests were performed using two bioindicators: Dugesia tigrina Girard and Daphnia magna Straus. D. tigrina was used for the first time to examine the toxicity of S. chartarum. The ecotoxicological tests showed that the analyzed strain belonged to the third and fourth toxicity classes according to Liebmann’s classification. The strain of S. chartarum was moderately toxic on Potato Dextrose Agar (PDA) as a culture medium (toxicity class III), and slightly toxic on Malt Extract Agar (MEA) (toxicity class IV). Toxicity was additionally tested by instrumental analytical methods (LC-MS/MS). This method allowed for the identification of 13 metabolites (five metabolites reported for Stachybotrys and eight for unspecific metabolites). Spirocyclic drimanes were detected in considerable quantities (ng/g); a higher concentration was observed for stachybotryamide (109,000 on PDA and 62,500 on MEA) and lower for stachybotrylactam (27,100 on PDA and 46,300 on MEA). Both may explain the result observed through the bioindicators. Highly toxic compounds such as satratoxins were not found in the sample. This confirms the applicability of the two bioindicators, which also show mutual compatibility, as suitable tools to assess the toxicity of moulds.

scholarly journals The Clinical Effect of Oral Vitamin D2 Supplementation on Psoriasis: A Double-Blind, Randomized, Placebo-Controlled Study

2019 ◽  
Vol 2019 ◽  
pp. 1-9 ◽  
Author(s):  
Wareeporn Disphanurat ◽  
Wongsiya Viarasilpa ◽  
Panlop Chakkavittumrong ◽  
Padcha Pongcharoen
Keyword(s):  
Vitamin D ◽  
Placebo Group ◽  
Adverse Events ◽  
Clinical Effect ◽  
Vitamin D Supplementation ◽  
P Value ◽  
Vitamin D2 ◽  
Oral Vitamin ◽  
Pasi Score ◽  
The Mean

Background. There are limited randomized controlled trials of oral vitamin D supplementation in psoriasis, especially in Asia, and the results are inconclusive. Objective. To investigate the clinical effect of oral vitamin D supplementation on psoriasis. Methods. Patients with psoriasis were randomized to receive vitamin D2 60,000 IU or similar-looking placebo pills once every 2 weeks for 6 months. The primary outcome was improvement of the Psoriasis Area and Severity Index (PASI) score at 3 and 6 months after treatment. Serum levels of 25(OH)D, calcium, phosphate, parathyroid hormone, and C-reactive protein and adverse events were monitored. The chi-square test, Fisher’s exact test, Student’s t-test, and Spearman’s correlation analysis were used in statistical analysis. Results. Of 50 subjects screened, 45 were eligible and randomized to the oral vitamin D2 group (n=23) or placebo group (n=22). At enrollment, the mean PASI score was 4.45, and 26.7% of patients had vitamin D deficiency. At 3 months, the oral vitamin D2 group had significantly higher PASI improvement than the placebo group (mean PASI improvement: 1.43 versus [vs.] -0.33, p-value=0.034; mean %PASI improvement: 34.21% vs. -1.85%, p-value=0.039). The mean serum 25(OH)D level was significantly higher in the oral vitamin D group than in the placebo group (27.4 vs. 22.4 ng/mL, p-value=0.029). Serum 25(OH)D concentrations were significantly inversely correlated with PASI scores at the 6-month follow-up. No major adverse event was observed overall. Conclusion. Oral vitamin D2 supplementation in patients with psoriasis increased the serum vitamin D level and significantly improved the treatment outcome without increasing adverse events. Trial Registration. This trial is registered with Thai Clinical Trials Registry TCTR20180613001.

UV Irradiation, Vitamin D, and Essential Hypertension

1990 ◽  
Vol 5 (10) ◽  
pp. 906-906
Author(s):  
N. Posthuma ◽  
P. T. A. M. Lips ◽  
A. J. M. Donker
Keyword(s):  
Vitamin D ◽  
Essential Hypertension ◽  
Uv Irradiation

Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease

1985 ◽  
Vol 69 (5) ◽  
pp. 561-570 ◽  
Author(s):  
E. Barbara Mawer ◽  
H. J. Klass ◽  
T. W. Warnes ◽  
Jacqueline L. Berry
Keyword(s):  
Vitamin D ◽  
Liver Disease ◽  
Primary Biliary Cirrhosis ◽  
Alcoholic Liver Disease ◽  
Vitamin D3 ◽  
Control Group ◽  
Biliary Cirrhosis ◽  
Vitamin D2 ◽  
Dihydroxyvitamin D3 ◽  
Poor Renal Function

1. The metabolism of isotopically labelled vitamin D2 and D3 has been investigated in eight patients with primary biliary cirrhosis and in five controls. The concentration of labelled vitamin D2 was lower than that of vitamin D3 in serum of patients with primary biliary cirrhosis on days 1 and 2 after intravenous injection (P < 0.005 and P < 0.05, respectively) but no difference was seen in controls. 2. Similar amounts of labelled 25-hydroxyvitamin D2 and D3 were seen in serum of the control group; the same pattern was observed in the primary biliary cirrhosis group, and no significant differences were observed between the two groups. 3. In both control and primary biliary cirrhosis groups, the serum concentration of labelled 24,25-dihydroxyvitamin D2 exceeded that of 24,25-dihydroxyvitamin D3 (significant for controls on day 2, P < 0.02) but concentrations in the two groups were not different. 4. Concentrations of labelled 25,26-dihydroxyvitamin D3 were significantly higher than those of 25,26-dihydroxyvitamin D2 in the primary biliary cirrhosis group at all times and in the control group on days 2 and 3. Both 25,26-dihydroxyvitamin D2 and D3 were higher in the serum of patients with primary biliary cirrhosis than in controls (significant on day 1, P < 0.05). 5. Urinary excretion over days 0–3 of radioactivity from both vitamins D2 and D3 was significantly higher in the primary biliary cirrhosis group than in controls: 12.03 vs 1.80% for vitamin D2 and 8.98 vs 1.76% for vitamin D3(P < 0.005). Vitamin D2-derived urinary radioactivity in primary biliary cirrhosis correlated strongly with serum bilirubin (P = 0.005). 6. The metabolism of labelled vitamin D3 was studied in seven patients with alcoholic liver disease, three of whom showed low serum concentrations of labelled 25-hydroxyvitamin D3 suggesting impaired hepatic synthesis. The 25-hydroxylation response was quantified as the relative index of 25-hydroxylation and was significantly related to two other indices of liver function. It is concluded that impaired 25-hydroxylation of vitamin D may occur in alcoholic liver disease and results from hepatocellular dysfunction. 7. Less than the predicted amounts of 1,25-dihydroxyvitamin D3 were produced in four of the seven patients with alcoholic liver disease; this defect may be attributable in part to decreased precursor 25-hydroxyvitamin D and to poor renal function.

Microcystin Exposure Pathways and Human Health

2020 ◽  
pp. 1-5
Author(s):  
Rajesh Melaram ◽  
Keyword(s):  
Public Health ◽  
Policy Development ◽  
Mitigation Strategies ◽  
World Health ◽  
Health Concern ◽  
Human Populations ◽  
Algal Toxins ◽  
Potential Health ◽  
Exposure Pathways ◽  
Green Algal

Microcystins (MCs) are blue-green algal toxins produced by freshwater cyanobacteria. Their environmentally relevant concentrations throughout global surface waters have tampered with human populations’ drinking and recreational supplies. MCs have gained immense public health attention due to their potential health effects. Microcystin-LR (MC-LR) is the most toxic variant of the MCs. Investigations on MC-LR toxicity and detection in water signify a growing potential environmental health concern worldwide. The World Health Organization established a provisional drinking water guidance value of 1 μg/L and a provisional recreational exposure guidance value of 10 μg/L for MC-LR. This review surveys human MC exposure pathways and integrates epidemiological studies to support MCs’ critical exposure pathways. A discussion on monitoring and mitigation strategies provides a guide for policy development in adopting MCs’ regulatory levels to protect public health.

Sign in / Sign up

Export Citation Format

Share Document